CERO THERAPEUTICS HOLDINGS, INC. Investing Cash Flow
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Investing Cash Flow of -$7.94 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was -$13.82M, a 107.65% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $5.69M.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $285.24K.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-03-31 was -$100.00K.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$7.94M, a 104.39% decline from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2022 was $180.84M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 4 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 7 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | -$13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | -$8.13M derived: sum of 2 quarters · filed 2024-04-02 | -$7.84M derived: sum of 3 quarters · filed 2024-04-02 | -$7.94M 10-K · filed 2024-04-02 | ||
| 2023-09-30 | $5.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.97M derived: sum of 2 quarters · filed 2023-11-09 | $5.87M 10-Q · filed 2023-11-09 | $186.58M derived: sum of 4 quarters · filed 2024-04-02 | ||
| 2023-06-30 | $285.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $185.24K 10-Q · filed 2023-08-14 | $180.90M derived: sum of 3 quarters · filed 2024-04-02 | |||
| 2023-03-31 | -$100.00K 10-Q · filed 2023-05-12 | $180.61M derived: sum of 2 quarters · filed 2024-04-02 | ||||
| 2022-12-31 | $180.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $180.84M 10-K · filed 2024-04-02 | ||||
| 2022-09-30 | $128.49K 10-Q · filed 2023-11-09 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | |||||
| 2021-12-31 | -$178.50M 10-K · filed 2023-03-24 | |||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |